SONM · Forms 3, 4, 5

Insider trades at DNA X, Inc.

No open-market insider buys or sells at DNA X, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.

Every Form 3, 4 and 5 filed for DNA X, Inc. (SONM) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Most recent insider filings

No Form 3, 4 or 5 filings for DNA X, Inc. in the last 90 days. The latest ones on EDGAR:

DateInsiderRoleTransactionSharesPriceValueFiling
DNA Holdings Venture Inc.10% ownerBecame an insider (Form 3)Form 3
Clayton CroliusChief Financial OfficerAward35,000Form 4
Michael C MulicaActing CEOAward50,000Form 4
George ThangaduraiDirectorBecame an insider (Form 3)Form 3
Laurence W Lytton10% ownerOptions or other derivativesForm 4
Laurence W Lytton10% ownerSell400,514$1.39$557KForm 4
Laurence W Lytton10% ownerSell466,402$1.50$700KForm 4
Laurence W Lytton10% ownerBecame an insider (Form 3)Form 3
Laurence W Lytton10% ownerOptions or other derivativesForm 4
Charles BecherSee RemarksSell31,326$1.45$45KForm 4
Michael C MulicaDirectorSell27,818$1.45$40KForm 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.